Molecular biology, pathogenesis and pathology of mumps virus

被引:157
作者
Rubin, Steven [1 ]
Eckhaus, Michael [2 ]
Rennick, Linda J. [4 ]
Bamford, Connor G. G. [3 ]
Duprex, W. Paul [4 ]
机构
[1] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA
[2] NIH, Div Vet Resources, Bethesda, MD 20892 USA
[3] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland
[4] Boston Univ, Dept Microbiol, Sch Med, Boston, MA 02215 USA
关键词
mumps; mumps virus; pathogenesis; neurovirulence; vaccine; CENTRAL-NERVOUS-SYSTEM; AQUEDUCTAL STENOSIS; CONGENITAL HYDROCEPHALUS; INTRAUTERINE INFECTION; UNIVERSITY-STUDENTS; VIRAL-INFECTION; INNER-EAR; P-GENE; VACCINE; OUTBREAK;
D O I
10.1002/path.4445
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mumps is caused by the mumps virus (MuV), a member of the Paramyxoviridae family of enveloped, non-segmented, negative-sense RNA viruses. Mumps is characterized by painful inflammatory symptoms, such as parotitis and orchitis. The virus is highly neurotropic, with laboratory evidence of central nervous system (CNS) infection in approximately half of cases. Symptomatic CNS infection occurs less frequently; nonetheless, prior to the introduction of routine vaccination, MuV was a leading cause of aseptic meningitis and viral encephalitis in many developed countries. Despite being one of the oldest recognized diseases, with a worldwide distribution, surprisingly little attention has been given to its study. Cases of aseptic meningitis associated with some vaccine strains and a global resurgence of cases, including in highly vaccinated populations, has renewed interest in the virus, particularly in its pathogenesis and the need for development of clinically relevant models of disease. In this review we summarize the current state of knowledge on the virus, its pathogenesis and its clinical and pathological outcomes. Copyright (c) 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:242 / 252
页数:11
相关论文
共 169 条
[1]  
Advisory Committee on Immunization Practices Centers for Disease Control and PreventionImmunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011, MMWR Recomm Rep, V60, P1, DOI DOI 10.1001/jamahealthforum.2021.0325
[2]   Evaluation of the neurovirulence test for mumps vaccines [J].
Afzal, MA ;
Marsden, SA ;
Hull, RM ;
Pipkin, PA ;
Bentley, ML ;
Minor, PD .
BIOLOGICALS, 1999, 27 (01) :43-49
[3]   THE EPIDEMIOLOGY OF MUMPS IN THE UK - A PRELIMINARY-STUDY OF VIRUS TRANSMISSION, HERD-IMMUNITY AND THE POTENTIAL IMPACT OF IMMUNIZATION [J].
ANDERSON, RM ;
CROMBIE, JA ;
GRENFELL, BT .
EPIDEMIOLOGY AND INFECTION, 1987, 99 (01) :65-84
[4]   A Case of Corneal Endotheliitis with Mumps Virus RNA in Aqueous Humor Detected by RT-PCR [J].
Ando, Kiyomu ;
Ishihara, Mami ;
Kusumoto, Yoshifumi ;
Shibuya, Etsuko ;
Nakamura, Satoshi ;
Mizuki, Nobuhisa .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2013, 21 (02) :150-152
[5]   The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter [J].
Andrejeva, J ;
Childs, KS ;
Young, DF ;
Carlos, TS ;
Stock, N ;
Goodbourn, S ;
Randall, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) :17264-17269
[6]  
ARITA M, 1981, BRIT HEART J, V46, P342
[7]   MUMPS MENINGOENCEPHALITIS IN CHILDREN [J].
AZIMI, PH ;
CRAMBLET.HG ;
HAYNES, RE .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 207 (03) :509-&
[8]   Immunization coverage and natural infection rates of vaccine-preventable diseases among children by questionnaire survey in 2005 in Japan [J].
Baba, Koichi ;
Okuno, Yoshinobu ;
Tanaka-Taya, Keiko ;
Okabe, Nobuhiko .
VACCINE, 2011, 29 (16) :3089-3092
[9]  
Bang HO, 1943, ACTA MED SCAND, V113, P487
[10]   A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia [J].
Bangor-Jones, Revle D. ;
Dowse, Gary K. ;
Giele, Carolien M. ;
van Buynder, Paul G. ;
Hodge, Meredith M. ;
Whitty, Mary M. .
MEDICAL JOURNAL OF AUSTRALIA, 2009, 191 (07) :398-401